Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Analysis of Patient Characteristics and Risk Factors for Thrombosis After Surgery for Congenital Heart Disease.

Murphy LD, Benneyworth BD, Moser EAS, Hege KM, Valentine KM, Mastropietro CW.

Pediatr Crit Care Med. 2018 Dec;19(12):1146-1152. doi: 10.1097/PCC.0000000000001743.

PMID:
30234677
2.

Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer.

Hege KM, Bergsland EK, Fisher GA, Nemunaitis JJ, Warren RS, McArthur JG, Lin AA, Schlom J, June CH, Sherwin SA.

J Immunother Cancer. 2017 Mar 21;5:22. doi: 10.1186/s40425-017-0222-9. eCollection 2017.

3.

Pulsed Radiation Therapy With Concurrent Cisplatin Results in Superior Tumor Growth Delay in a Head and Neck Squamous Cell Carcinoma Murine Model.

Meyer K, Krueger SA, Kane JL, Wilson TG, Hanna A, Dabjan M, Hege KM, Wilson GD, Grills I, Marples B.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):161-9. doi: 10.1016/j.ijrobp.2016.04.031. Epub 2016 May 7.

PMID:
27511853
5.

Oxygenation index predicts mortality in pediatric stem cell transplant recipients requiring mechanical ventilation.

Rowan CM, Hege KM, Speicher RH, Goodman M, Perkins SM, Slaven JE, Westenkirchner DF, Haut PR, Nitu ME.

Pediatr Transplant. 2012 Sep;16(6):645-50. doi: 10.1111/j.1399-3046.2012.01745.x. Epub 2012 Jun 18.

PMID:
22708708
6.

Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.

Scholler J, Brady TL, Binder-Scholl G, Hwang WT, Plesa G, Hege KM, Vogel AN, Kalos M, Riley JL, Deeks SG, Mitsuyasu RT, Bernstein WB, Aronson NE, Levine BL, Bushman FD, June CH.

Sci Transl Med. 2012 May 2;4(132):132ra53. doi: 10.1126/scitranslmed.3003761.

7.

Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).

Borrello IM, Levitsky HI, Stock W, Sher D, Qin L, DeAngelo DJ, Alyea EP, Stone RM, Damon LE, Linker CA, Maslyar DJ, Hege KM.

Blood. 2009 Aug 27;114(9):1736-45. doi: 10.1182/blood-2009-02-205278. Epub 2009 Jun 25.

8.

Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic, cellular immunotherapy.

Urba WJ, Nemunaitis J, Marshall F, Smith DC, Hege KM, Ma J, Nguyen M, Small EJ.

J Urol. 2008 Nov;180(5):2011-7; discussion 2017-8. doi: 10.1016/j.juro.2008.07.048. Epub 2008 Sep 17.

PMID:
18801509
9.

GM-CSF gene-modifed cancer cell immunotherapies: of mice and men.

Hege KM, Jooss K, Pardoll D.

Int Rev Immunol. 2006 Sep-Dec;25(5-6):321-52. Review.

PMID:
17169779
10.

Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancer.

Simons JW, Carducci MA, Mikhak B, Lim M, Biedrzycki B, Borellini F, Clift SM, Hege KM, Ando DG, Piantadosi S, Mulligan R, Nelson WG.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3394-401.

11.
12.

Lung cancer vaccines and gene therapy.

Hege KM, Carbone DP.

Lung Cancer. 2003 Aug;41 Suppl 1:S103-13. Review.

PMID:
12867069
13.

Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects.

Anton PA, Mitsuyasu RT, Deeks SG, Scadden DT, Wagner B, Huang C, Macken C, Richman DD, Christopherson C, Borellini F, Lazar R, Hege KM.

AIDS. 2003 Jan 3;17(1):53-63.

PMID:
12478069
14.

A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.

Deeks SG, Wagner B, Anton PA, Mitsuyasu RT, Scadden DT, Huang C, Macken C, Richman DD, Christopherson C, June CH, Lazar R, Broad DF, Jalali S, Hege KM.

Mol Ther. 2002 Jun;5(6):788-97.

15.

Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects.

Mitsuyasu RT, Anton PA, Deeks SG, Scadden DT, Connick E, Downs MT, Bakker A, Roberts MR, June CH, Jalali S, Lin AA, Pennathur-Das R, Hege KM.

Blood. 2000 Aug 1;96(3):785-93.

16.

Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.

Walker RE, Bechtel CM, Natarajan V, Baseler M, Hege KM, Metcalf JA, Stevens R, Hazen A, Blaese RM, Chen CC, Leitman SF, Palensky J, Wittes J, Davey RT Jr, Falloon J, Polis MA, Kovacs JA, Broad DF, Levine BL, Roberts MR, Masur H, Lane HC.

Blood. 2000 Jul 15;96(2):467-74.

17.
18.

T-cell gene therapy.

Hege KM, Roberts MR.

Curr Opin Biotechnol. 1996 Dec;7(6):629-34. Review.

PMID:
8939644
19.

Supplemental Content

Support Center